WHO ICTRP trial
Efficacy of microwave ablation combined with oxitinib in the treatment of EGFR +…
ChiCTR2100049832 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2100049832 |
|---|---|
| Public title | Efficacy of microwave ablation combined with oxitinib in the treatment of EGFR + advanced non-small cell lung cancer |
| Scientific title | Efficacy of microwave ablation combined with oxitinib in the treatment of EGFR + advanced non-small cell lung cancer |
| Primary sponsor | Zhongshan Hospital of Traditional Chinese Medicine Affiliated to Guangzhou University of Traditional Chinese Medicine |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 0 |
| Countries | China |
| Conditions | non-small cell lung cancer |
| Interventions | Experimental group:Osimertinib mesylate |
| Registration date | Aug 10, 2021 |
| Target size | Experimental group:30 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: